Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
A closer look at pacritinib: A JAK2/FLT3 inhibitor for the treatment of myelofibrosis
Leslie Padrnos, Ruben A. Mesa
Hematology/Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A closer look at pacritinib: A JAK2/FLT3 inhibitor for the treatment of myelofibrosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
100%
Janus Kinase 2
71%
Primary Myelofibrosis
63%
INCB018424
34%
Therapeutics
8%
Janus Kinase Inhibitors
7%
Transplants
7%
Splenomegaly
6%
Allogeneic Cells
6%
Expert Testimony
5%
Palliative Care
5%
Thrombocytopenia
5%
Protein-Tyrosine Kinases
5%
Leukemia
4%
Spleen
4%
Stem Cells
4%
Quality of Life
3%
Neoplasms
1%
Social Sciences
adverse events
45%
Clinical Benefit
26%
candidacy
25%
expert opinions
19%
medication
14%
quality of life
13%